Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.539
-0.022 (-1.38%)
Nov 21, 2024, 1:14 PM EST - Market open

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
12454321127291
Upgrade
Market Cap Growth
134.34%67.34%-71.06%56.56%-21.55%23.29%
Upgrade
Enterprise Value
11324-16905984
Upgrade
Last Close Price
1.560.840.511.852.183.54
Upgrade
PS Ratio
---1803.25--
Upgrade
PB Ratio
18.022.540.841.866.888.08
Upgrade
P/TBV Ratio
18.022.560.851.877.138.39
Upgrade
EV/Sales Ratio
---1441.08--
Upgrade
Debt / Equity Ratio
0.020.010.000.000.010.01
Upgrade
Asset Turnover
---0.00--
Upgrade
Quick Ratio
2.324.246.117.295.6611.42
Upgrade
Current Ratio
2.494.366.277.535.9420.81
Upgrade
Return on Equity (ROE)
-159.53%-69.93%-48.16%-70.69%-147.74%-74.08%
Upgrade
Return on Assets (ROA)
-79.07%-37.71%-34.47%-46.58%-82.38%-36.99%
Upgrade
Return on Capital (ROIC)
-104.92%-46.14%-40.17%-53.83%-91.42%-39.75%
Upgrade
Earnings Yield
-21.51%-39.19%-70.37%-22.28%-22.60%-11.55%
Upgrade
FCF Yield
-14.95%-35.17%-62.10%-16.58%-10.04%-9.96%
Upgrade
Buyback Yield / Dilution
-5.66%-3.13%-44.61%-44.77%-15.63%-67.97%
Upgrade
Total Shareholder Return
-5.66%-3.13%-44.61%-44.77%-15.63%-67.97%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.